Grants
Cycle 2: Broad PCORI Funding Announcements
Sponsor: Patient-Centered Outcomes Research Institute LOI Due Date: May 29, 2019 by 5 pm ET Application Due Date: September 4, 2019 by 5 pm Award: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; and Improving Hea...
May 29Training Institute for Dissemination and Implementation Research in Health
Sponsors: NIH, US Department of Veterans Affairs, US Department of Health and Human Services Application Due Date: June 23, 2019, by 8:00 PM EDT Award and Eligibility: This training is designed for doctoral-level investigators at any career stage in...
June 23 @ 8:00 pmCycle 2: NIH R01 and U01
DUE DATE: JULY 5, 2019 NINDS Exploratory Clinical Trials (U01) The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurologi...
July 5Cycle 4: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)
Sponsor: National Institutes of Health (multiple Institutes) LOI Due Date: July 7, 2019 Application Due Date: August 9, 2019 Award: Actual needs; applicants should rarely exceed up to $500,000 total cost per year for Phase I and up to $1,500,000 to...
July 7Cycle 3: Alzheimer’s Drug Discovery Foundation
LOI DUE JULY 12, 2019 Drug Discovery Program Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research ...
July 12Cycle 3: Whitehall Foundation Grants-in-Aids
Sponsor: Whitehall Foundation, Inc. LOI Due Date: October 1, 2019 Application Due Date: February 15, 2020 Award: Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.
October 1Cycle 3: Whitehall Foundation Research Grants
Sponsor: Whitehall Foundation, Inc. LOI Due Date: October 1, 2019 Application Due Date: February 15, 2020 Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.
October 1Cycle 4: Alzheimer’s Drug Discovery Foundation
LOI DUE OCTOBER 11, 2019 Drug Discovery Program The Drug Discovery RFP supports novel drug programs and repurposed/repositioned programs. One year with potential for follow-on funding; average award is $150,000-$600,000 based on stage and scope of r...
October 11Cycle 3: Prevention Research in Mid-Life Adults (R01)
Sponsor: National Institutes of Health Due Date: November 5, 2019 by 5 pm local time of applicant Award: Money, property, or both to carry out an approved project or activity. The number of awards is contingent upon NIH appropriations and the submiss...
November 5Rolling Basis: Alzheimer’s Drug Discovery Foundation
PROPOSALS ACCEPTED ON A ROLLING BASIS ADDF/NIH Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. Conference Funding Supports scientific conferences that are re...
December 31ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award
Sponsor: International Rett Syndrome Foundation (IRSF) Due Date: Applications accepted on a rolling basis Award: Up to $600,000 over two years
January 1, 2020Cycle 1: Whitehall Foundation Grants-In-Aid
Sponsor: Whitehall Foundation, Inc. LOI Due Date: January 15, 2020 Application Due Date: June 1, 2020 Award: Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.
January 1, 2020Cycle 1: Whitehall Foundation Research Grants
Sponsor: Whitehall Foundation, Inc. LOI Due Date: January 15, 2020 Application Due Date: June 1, 2020 Award: Research grants normally range from $30,000 to $75,000 per year for up to three years.
January 15, 2020